Senior CDER Management Panel Could Facilitate Novel Therapy Approval
By
Cathy Dombrowski / Email the Author / Pharmaceutical Approvals Monthly January 2012, Vol. 17, No. 1
FDA Policy / Word Count: 460 / Article # 06120101013
Executive Summary
CDER Director Janet Woodcock is creating an executive-level forum to deliberate medical policies, including those needed to smooth drug reviews. She envisions stakeholder input on topics for discussion by the panel.
$35.00
Buy Now
For $35.00, purchase this 460-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.